These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9385061)

  • 81. Posttranslational modifications of tau in paired helical filaments.
    Morishima M; Ihara Y
    Dementia; 1994; 5(5):282-8. PubMed ID: 7951685
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Alzheimer paired helical filaments: cross-reacting polypeptide/s normally present in brain.
    Grundke-Iqbal I; Iqbal K; Tung YC; Wang GP; Wisniewski HM
    Acta Neuropathol; 1985; 66(1):52-61. PubMed ID: 2581415
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Subunit structure of paired helical filaments in Alzheimer's disease.
    Wischik CM; Crowther RA; Stewart M; Roth M
    J Cell Biol; 1985 Jun; 100(6):1905-12. PubMed ID: 2581978
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Tau, amyloid and Alzheimer's disease].
    Olesen OF
    Ugeskr Laeger; 1994 Feb; 156(8):1116-7, 1121-4. PubMed ID: 8116089
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Antibodies to the neuronal cytoskeleton are elicited by Alzheimer paired helical filament fractions.
    Perry G; Friedman R; Kang DH; Manetto V; Autilio-Gambetti L; Gambetti P
    Brain Res; 1987 Sep; 420(2):233-42. PubMed ID: 3676758
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Beta-amyloid deposition and paired helical filament formation: which histopathological feature is more significant in Alzheimer's disease?
    Dickson DW; Yen SH
    Neurobiol Aging; 1989; 10(5):402-4; discussion 412-4. PubMed ID: 2682317
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.
    Yan SD; Yan SF; Chen X; Fu J; Chen M; Kuppusamy P; Smith MA; Perry G; Godman GC; Nawroth P
    Nat Med; 1995 Jul; 1(7):693-9. PubMed ID: 7585153
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
    Mirabella M; Alvarez RB; Bilak M; Engel WK; Askanas V
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):774-86. PubMed ID: 8965093
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Alzheimer's Disease-like Paired Helical Filament Assembly from Truncated Tau Protein Is Independent of Disulfide Crosslinking.
    Al-Hilaly YK; Pollack SJ; Vadukul DM; Citossi F; Rickard JE; Simpson M; Storey JMD; Harrington CR; Wischik CM; Serpell LC
    J Mol Biol; 2017 Nov; 429(23):3650-3665. PubMed ID: 28919235
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Quantitative Characterization of Metastability and Heterogeneity of Amyloid Aggregates.
    Sil TB; Sahoo B; Bera SC; Garai K
    Biophys J; 2018 Feb; 114(4):800-811. PubMed ID: 29490242
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Challenges in Peptide Solubilization - Amyloids Case Study.
    Polańska O; Szulc N; Stottko R; Olek M; Nadwodna J; Gąsior-Głogowska M; Szefczyk M
    Chem Rec; 2024 Aug; 24(8):e202400053. PubMed ID: 39023378
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Involvement of Maillard reactions in Alzheimer disease.
    Reddy VP; Obrenovich ME; Atwood CS; Perry G; Smith MA
    Neurotox Res; 2002 May; 4(3):191-209. PubMed ID: 12829400
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Solubilization of Human Interferon β-1b Inclusion Body Proteins by Organic Solvents.
    Nekoufar S; Fazeli A; Fazeli MR
    Adv Pharm Bull; 2020 Jun; 10(2):233-238. PubMed ID: 32373491
    [No Abstract]   [Full Text] [Related]  

  • 94. Extraction of Soluble and Insoluble Protein Fractions from Mouse Brains and Spinal Cords.
    Wirths O
    Bio Protoc; 2017 Aug; 7(15):e2422. PubMed ID: 34541150
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Solubilization, migration, and utilization of insoluble matter in nature.
    MANDL I; NEUBERG C
    Adv Enzymol Relat Subj Biochem; 1956; 17():135-58. PubMed ID: 13313308
    [No Abstract]   [Full Text] [Related]  

  • 96. The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.
    Dugger BN; Whiteside CM; Maarouf CL; Walker DG; Beach TG; Sue LI; Garcia A; Dunckley T; Meechoovet B; Reiman EM; Roher AE
    J Alzheimers Dis; 2016; 51(2):345-56. PubMed ID: 26890756
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Protocol for quantitative analysis of paired helical filament solubilization: a method applicable to insoluble amyloids and inclusion bodies.
    Smith MA; Nagaraj RH; Perry G
    Brain Res Brain Res Protoc; 1997 Aug; 1(3):247-52. PubMed ID: 9385061
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease.
    Smith MA; Siedlak SL; Richey PL; Nagaraj RH; Elhammer A; Perry G
    Brain Res; 1996 Apr; 717(1-2):99-108. PubMed ID: 8738259
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Purification and solubilization of paired helical filaments from Alzheimer brains.
    Vogelsang GD; Zemlan FP; Dean GE
    J Neurochem; 1990 Jan; 54(1):148-55. PubMed ID: 2293607
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
    Keck S; Nitsch R; Grune T; Ullrich O
    J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.